Loss-of-function of ACVR1 in osteoblasts increases bone mass and activates canonical Wnt signaling through suppression of Wnt inhibitors SOST and DKK1
- 1 October 2011
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 414 (2) , 326-330
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Osteoporosis: now and the futureThe Lancet, 2011
- New insights on the roles of BMP signaling in bone—A review of recent mouse genetic studiesBioFactors, 2011
- Conversion of vascular endothelial cells into multipotent stem-like cellsNature Medicine, 2010
- Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP)Journal of Bone and Mineral Metabolism, 2008
- Fibrodysplasia ossificans progressivaBest Practice & Research Clinical Rheumatology, 2008
- Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusionInternational Orthopaedics, 2007
- BMP type I receptor ALK2 is essential for proper patterning at late gastrulation during mouse embryogenesisDevelopmental Dynamics, 2006
- Regulation of bone mass by Wnt signalingJournal of Clinical Investigation, 2006
- Bone Morphogenetic ProteinsGrowth Factors, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001